Neoadjuvant immunotherapy may facilitate surgery, improve outcomes for patients with high-risk liver cancer
Patients with liver cancer who received immune checkpoint inhibitors (ICIs) before surgery—including those who would not have been eligible for surgery by conventional criteria—had similar outcomes to patients who received ...
Aug 15, 2024
0
37
